Actively Recruiting
Case-Specific Health Care Professional Clinical Survey of Liberant™ Thrombectomy System
Led by Medtronic Endovascular · Updated on 2026-05-12
50
Participants Needed
1
Research Sites
31 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of Case-Specific Health Care Professional (HCP) Clinical Survey of Liberant™ Thrombectomy System, also known as the Liberant Clinical Assessment, is to collect first-in-human clinical data to confirm the safety and performance of the Medtronic Liberant™ thrombectomy system when used for the removal of fresh, soft emboli or thrombi from the vessels of the peripheral arterial and venous systems
CONDITIONS
Official Title
Case-Specific Health Care Professional Clinical Survey of Liberant™ Thrombectomy System
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patient treated is age 2 years or older at the time of procedure
- Use of Liberant in accordance with the device labeling within 72 hours of the index procedure
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Naples Comprehensive Health
Naples, Florida, United States, 34108
Actively Recruiting
Research Team
M
Manasa Gudipally
CONTACT
J
Janki Shah
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here